March 3, 2020 / 12:50 PM / a month ago

BRIEF-Neuraly Announces First Patient Dosed In Mid-Stage Trial For Parkinson's Disease

March 3 (Reuters) - Neuraly:

* NEURALY ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF NYL01 FOR PATIENTS WITH PARKINSON’S DISEASE Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below